ViraTherapeutics is a subsidiary of the Boehringer Ingelheim group of companies: a perfect symbiosis of big pharma and a biotech start-up vibe. Located in the beautiful city of Innsbruck, Austria – a great place to live and to work – our dedicated Research & Development team develops innovative viral-based immune-oncology treatment options.